Open Text Corporation vs Tempus AI — how do they compare? Open Text Corporation trades at $23.37 (market cap $5.61B), while Tempus AI trades at $70.3 (market cap $12.58B). The key difference: Tempus AI is far larger — about 2.2× Open Text Corporation's market cap, and Open Text Corporation pays a 4.82% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Open Text Corporation for 23 Days and Tempus AI for 22 Days on average.
| OTEX | TEM | |
|---|---|---|
Market Cap | $5.61B | $12.58B |
Volume | 1,197,475 | 7,444,569 |
Sector | Technology | Broad Market / Factor |
52-Week High | $39.69 | $99.28 |
52-Week Low | $20.01 | $41.55 |
Typical Hold Time | 23 Days | 22 Days |
Enterprise Value | $10.63B | $13.21B |
Dividend Yield | 4.82% | — |
Signals from Pluang's Aura AI — not financial advice
OpenText (OTEX) trades at $23.14, up 1.89% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with a P/E of 8.97 and consistent earnings beats, including Q2 2026 EPS of $1.23 beating expectations by 20.6%. Recent debt refinancing activities and a strategic AI partnership with Cohere highlight management's focus on growth and financial flexibility.
OTEX presents a compelling value opportunity with discounted valuation multiples and improving cloud momentum, though elevated debt levels and competitive pressures remain key risks. Analyst consensus targets $28.30 (22% upside) with 42% buy ratings, suggesting cautious optimism for the software company's transformation efforts.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →